Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-22-015590

Director sold 1,875 shares at an average $61.36 ($115,056)

  • Director acquired 1,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BOLGER JOHN C · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Exercise or conversion : show line 1 in the form +625 $3.93 $2,453 2,625 D
2022-03-01 Sale : show line 2 in the form −625 $61.42 $38,388 2,000 D
2022-03-01 Exercise or conversion : show line 3 in the form +625 $5.81 $3,631 2,625 D
2022-03-01 Sale : show line 4 in the form −625 $61.40 $38,376 2,000 D
2022-03-01 Exercise or conversion : show line 5 in the form +625 $15.82 $9,888 2,625 D
2022-03-01 Sale : show line 6 in the form −625 $61.27 $38,293 2,000 D
Open-market sales · 1,875 sh · avg $61.36 · $115,056

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-03-01 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −625 313 D
2022-03-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −625 1,563 D
2022-03-01 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −625 2,813 D
Loading xslF345X03/doc4.xml…